Ertaczo
Pricing Report NDC 0187-5115-60

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Ertaczo (NDC 0187-5115-60) is $12.14338 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 14, 2015.

As a provided by Bausch Health Us, Llc, this medication is distributed in a 1 TUBE in 1 CARTON / 60 g in 1 TUBE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$12.14338
Per GM

Effective Date
Aug 14, 2015
Billable Units
60 GM
Estimated Package Price
$728.60
Data Status
As of Aug 10, 2016
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 TUBE in 1 CARTON / 60 g in 1 TUBE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The NADAC was calculated based on package size.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Dec 2013, the NADAC wholesale price for (NDC ) has moved within a range of $4.91895 to $12.14338 per GM. Over this 1 year and 7 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$4.9190 - $12.1434
Market Volatility
146.87% Variance
Latest Trend
20.00%
Date Unit Price Unit Source Method Rate
Aug 14, 2015 $12.14338 GMC/I - Chain or Independent PharmacyCode 3, 5B - Brand
Aug 14, 2015 $12.14338 GMC/I - Chain or Independent PharmacyCode 4, 5B - Brand
May 01, 2015 $10.11957 GMC/I - Chain or Independent PharmacyCode 3, 5B - Brand
May 01, 2015 $10.11957 GMC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Jan 02, 2015 $8.43304 GMC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Jan 02, 2015 $8.43304 GMC/I - Chain or Independent PharmacyCode 3, 5B - Brand
Jan 02, 2015 $8.43304 GMC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Aug 01, 2014 $6.48695 GMC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Aug 01, 2014 $6.48695 GMC/I - Chain or Independent PharmacyCode 3, 5B - Brand
Aug 01, 2014 $6.48695 GMC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Jun 18, 2014 $5.64088 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jun 18, 2014 $5.64088 GMC/I - Chain or Independent PharmacyCode 4, 5B - Brand
May 21, 2014 $5.65475 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Dec 18, 2013 $4.91895 GMC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Dec 18, 2013 $4.91895 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Dec 18, 2013 $4.91895 GMC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026